Richard Barnard
Papers
1
Total Citations
6
H-Index
1
About
Dr. Richard Barnard is a leading researcher in HIV latency and eradication strategies, with a primary focus on developing and characterizing novel pharmacological interventions. His work centers on the critical challenge of eliminating latent HIV reservoirs, which prevent a complete cure for people living with HIV. Dr. Barnard’s major contribution includes pioneering the use of automated, high-throughput platforms for *in vitro* pharmacokinetic/pharmacodynamic (PK/PD) modeling, enabling precise evaluation of latency-reversing agents. His most cited paper, "In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform" (2021), with 6 citations, exemplifies this approach by systematically assessing histone deacetylase inhibitors (HDACis) for their ability to reactivate dormant HIV. This work provides a robust, reproducible framework for screening potential "shock and kill" therapies, directly addressing the major barrier of persistent HIV infection. Dr. Barnard’s research is instrumental in bridging preclinical drug development with clinical application, offering a pathway toward reducing or eliminating the need for lifelong antiretroviral therapy.
Research Focus
Key Achievements
Top Papers
- 1